Evaluation the effect of adding Sevelamer to the standard treatment of aluminum phosphide poisoning patients
Phase 2
Recruiting
- Conditions
- Aluminum phosphide poisoning.Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
- Registration Number
- IRCT20210720051946N7
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Taking the oral form of aluminum phosphide
Referral to Luqman Hospital within 24 hours
The presence of symptoms consistent with poisoning
Positive silver nitrate test
Carbon monoxide measurement above 10 in non-smokers
Exclusion Criteria
glomerular filtration rate less than 30
History of kidney failure
History of liver failure
History of acute myocardial infarction
History of congenital heart disease
History of heart failure during pregnancy and breastfeeding
Referral after 24 hours of taking rice tablets
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prognosis of patients poisoned with aluminum phosphide tablets referred to Luqman Hakim Hospital. Timepoint: Length of hospitalization. Method of measurement: Days.
- Secondary Outcome Measures
Name Time Method Mortality. Timepoint: Patient death or patient survival. Method of measurement: Yes or no.